| $100M | ||
| $50M | ||
| $22M | ||
| $19M | ||
| $3M | ||
| $2M |
Buys | $6,014,680 | 8 | 80 |
Sells | $644,379 | 2 | 20 |
| Fyrwald J Erik | CEO | 3 | $3.86M | 0 | $0 | $3.86M |
| Landsman Stephen N | EVP, General Counsel | 1 | $927,356 | 0 | $0 | $927,356 |
| O'Byrne Kevin | director | 2 | $865,073 | 0 | $0 | $865,073 |
| Khan Mehmood | director | 1 | $301,314 | 0 | $0 | $301,314 |
| Palau Hernandez Margarita | director | 1 | $65,807 | 0 | $0 | $65,807 |
| Yildiz Beril | CAO, SVP & Controller | 0 | $0 | 1 | $185,604 | $-185,604 |
| Arora Yuvraj | President, Nourish | 0 | $0 | 1 | $458,775 | $-458,775 |
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
Over the last 12 months, insiders at International Flavors & Fragrances Inc. have bought $6.01M and sold $644,379 worth of International Flavors & Fragrances Inc. stock.
On average, over the past 5 years, insiders at International Flavors & Fragrances Inc. have bought $3.08M and sold $531,344 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Fyrwald J Erik (CEO) — $3.86M. Landsman Stephen N (EVP, General Counsel) — $927,356. O'Byrne Kevin (director) — $865,073.
The last purchase of 4,500 shares for transaction amount of $342,240 was made by O'Byrne Kevin (director) on 2025‑05‑22.
| 2025-05-22 | O'Byrne Kevin | director | 4,500 0.0018% | $76.05 | $342,240 | +1.06% | ||
| 2025-05-19 | Sale | Yildiz Beril | CAO, SVP & Controller | 2,400 0.0009% | $77.33 | $185,604 | -0.77% | |
| 2025-05-19 | Landsman Stephen N | EVP, General Counsel | 12,000 0.0047% | $77.28 | $927,356 | -0.77% | ||
| 2025-05-19 | Palau Hernandez Margarita | director | 850 0.0003% | $77.42 | $65,807 | -0.77% | ||
| 2025-05-15 | Khan Mehmood | director | 4,000 0.0015% | $75.33 | $301,314 | +1.45% | ||
| 2025-05-09 | Fyrwald J Erik | Chief Executive Officer | 24,300 0.0096% | $73.97 | $1.8M | +3.59% | ||
| 2025-05-08 | Fyrwald J Erik | Chief Executive Officer | 700 0.0003% | $74.00 | $51,797 | +2.89% | ||
| 2025-03-05 | O'Byrne Kevin | director | 6,500 0.0025% | $80.44 | $522,833 | -5.15% | ||
| 2025-03-04 | Fyrwald J Erik | CEO | 25,000 0.0098% | $80.24 | $2.01M | -3.41% | ||
| 2024-11-11 | Sale | Arora Yuvraj | President, Nourish | 5,000 0.002% | $91.75 | $458,775 | -11.25% | |
| 2024-06-13 | Sale | Strzelecki Angela | President, Pharma Solutions | 2,588 0.001% | $95.66 | $247,560 | -6.99% | |
| 2023-05-11 | Sale | Fauchon de Villeplee Christophe | President, Scent | 1,972 0.0008% | $86.35 | $170,282 | -5.86% | |
| 2022-08-11 | Sale | Fortanet Francisco | EVP, Operations | 10,000 0.004% | $125.00 | $1.25M | -21.29% | |
| 2022-06-01 | Sale | Fauchon de Villeplee Christophe | President, Scent | 629 0.0002% | $132.59 | $83,399 | -22.49% | |
| 2022-05-02 | Sale | Fauchon de Villeplee Christophe | President, Scent | 630 0.0002% | $121.68 | $76,658 | -11.09% | |
| 2021-05-14 | GORDON ILENE S | director | 1,000 0.0004% | $140.39 | $140,386 | +2.21% | ||
| 2021-05-13 | Sale | Herriott Simon | President Health & Biosciences | 1,332 0.0005% | $138.47 | $184,442 | +4.07% | |
| 2020-04-16 | Sale | MIRZAYANTZ NICOLAS | Group President Fragrance | 312 0.0003% | $118.04 | $36,828 | +4.34% | |
| 2020-03-30 | Winder Investment Pte Ltd | director | 18,984 0.0175% | $111.30 | $2.11M | +14.99% | ||
| 2020-03-27 | Winder Investment Pte Ltd | 10 percent owner | 107,612 0.0967% | $111.06 | $11.95M | +12.54% |
| Fyrwald J Erik | Chief Executive Officer | 62070 0.0243% | $4.65M | 3 | 0 | |
| Landsman Stephen N | EVP, General Counsel | 12000 0.0047% | $898,680.00 | 1 | 0 | |
| O'Byrne Kevin | director | 7696 0.003% | $576,353.44 | 2 | 0 | |
| Khan Mehmood | director | 4604 0.0018% | $344,793.56 | 1 | 0 | |
| Yildiz Beril | CAO, SVP & Controller | 3321 0.0013% | $248,737.40 | 0 | 1 | |
| Arora Yuvraj | President, Nourish | 3238 0.0013% | $242,493.82 | 0 | 1 | |
| Palau Hernandez Margarita | director | 2393 0.0009% | $179,211.77 | 1 | 0 | |
| Winder Investment Pte Ltd | director | 24130000 9.4335% | $1.81B | 193 | 0 | +4.64% |
| HERZAN ALEXANDRA A | director | 519581 0.2031% | $38.91M | 0 | 8 | |
| GOLDSTEIN RICHARD A | Chairman & CEO | 213674 0.0835% | $16M | 0 | 5 | |
| AMEN ROBERT M | Chairman & CEO | 119852 0.0469% | $8.98M | 1 | 0 | <0.0001% |
| WETMORE DOUGLAS J | Senior VP, CFO and Treasurer | 80950 0.0316% | $6.06M | 1 | 6 | <0.0001% |
| MEANY DENNIS M | SVP, Gen.Counsel & Sec'y | 64700 0.0253% | $4.85M | 0 | 3 | |
| Berryman Kevin C | EVP & Chief Financial Officer | 48676 0.019% | $3.65M | 0 | 5 | |
| BROOKS CLINT D | Senior VP, R & D | 46215 0.0181% | $3.46M | 0 | 3 | |
| DUNSDON JAMES H | Chief Transition Officer | 43904 0.0172% | $3.29M | 0 | 5 | |
| Cantlon Angelica T. | EVP, Chief Human Resources | 40199 0.0157% | $3.01M | 0 | 6 | |
| Chwat Anne | EVP, GC, & Corp. Sec'y | 34561 0.0135% | $2.59M | 0 | 4 | |
| MIRZAYANTZ NICOLAS | Group President Fragrance | 32452 0.0127% | $2.43M | 0 | 46 | |
| HEASLIP STEVEN J | Senior VP Human Resources | 28333 0.0111% | $2.12M | 0 | 4 | |
| Baydar Ahmet | EVP, Research & Development | 24285 0.0095% | $1.82M | 0 | 6 | |
| Vaisman Hernan | Group President, Flavors | 20237 0.0079% | $1.52M | 0 | 9 | |
| Fortanet Francisco | EVP, Operations | 17237 0.0067% | $1.29M | 0 | 16 | |
| O'Leary Richard | EVP & Integration Officer | 17186 0.0067% | $1.29M | 0 | 6 | |
| HUETHER JAMES P | Corporate Controller | 9506 0.0037% | $711,904.34 | 0 | 2 | |
| Fauchon de Villeplee Christophe | President, Scent | 9093 0.0036% | $680,974.77 | 0 | 3 | |
| Strzelecki Angela | President, Pharma Solutions | 8539 0.0033% | $639,485.71 | 0 | 1 | |
| WELLER CHARLES D | VP and Treasurer | 7944 0.0031% | $594,926.16 | 0 | 1 | |
| BLOCK STEPHEN A | Senior Vice President | 7694 0.003% | $576,203.66 | 0 | 2 | |
| Gibson Christopher | VP Flavors, North America | 5704 0.0022% | $427,172.56 | 0 | 2 | |
| ADAME MARGARET HAYES | director | 4500 0.0018% | $337,005.00 | 0 | 3 | |
| MORRISON DALE F | director | 4010 0.0016% | $300,308.90 | 1 | 0 | +10.1% |
| MARTINEZ ARTHUR C | director | 3750 0.0015% | $280,837.50 | 0 | 2 | |
| EDELMAN ROB J M | VP and Regional Manager | 3410 0.0013% | $255,374.90 | 0 | 3 | |
| FERRO GRACIELA M | VP Global Accounts | 3187 0.0012% | $238,674.43 | 0 | 4 | |
| BEWOOR ARUN | VP, Regional Manager | 3000 0.0012% | $224,670.00 | 0 | 1 | |
| HUMPHREYS NEIL | Vice President | 2832 0.0011% | $212,088.48 | 0 | 2 | |
| HUDSON KATHERINE M | director | 2500 0.001% | $187,225.00 | 1 | 0 | +11.84% |
| BELMUTH GAIL S | President Corp. Comm. | 2616 0.001% | $195,912.24 | 0 | 1 | |
| Faranda Joseph | Chief Marketing Officer | 2285 0.0009% | $171,123.65 | 0 | 1 | |
| HOWARD D WAYNE | EVP Global Operations | 2096 0.0008% | $156,969.44 | 0 | 4 | |
| BOTTOLI MARCELLO | director | 2065 0.0008% | $154,647.85 | 2 | 0 | +7.26% |
| Herriott Simon | President Health & Biosciences | 1515 0.0006% | $113,435.51 | 0 | 1 | |
| GORDON ILENE S | director | 1255 0.0005% | $93,986.95 | 1 | 0 | +2.21% |
| Howell Henry W Jr | director | 1198 0.0005% | $89,718.22 | 0 | 1 | |
| BURNS ROBERT | Sr.VP, Regional Manager | 390 0.0002% | $29,207.10 | 0 | 4 | |
| Wall Dennis | Regional Manager | 369 0.0001% | $27,634.41 | 0 | 1 | |
| COOK J MICHAEL | director | 100 0% | $7,489.00 | 0 | 2 |
| Increased Positions | 338 | +38.58% | 18M | +7.01% |
| Decreased Positions | 374 | -42.69% | 13M | -4.87% |
| New Positions | 75 | New | 2M | New |
| Sold Out Positions | 106 | Sold Out | 3M | Sold Out |
| Total Postitions | 840 | -4.11% | 268M | +2.14% |
| Dodge & Cox | $2.49M | 12.28% | 31.44M | +3M | +11.95% | 2024-12-31 |
| Vanguard Group Inc | $2.39M | 11.8% | 30.22M | +164,945 | +0.55% | 2024-12-31 |
| Winder Pte. Ltd. | $2M | 9.9% | 25.36M | 0 | 0% | 2024-09-30 |
| Freemont Capital Pte Ltd | $2M | 9.9% | 25.36M | +25M | New | 2024-12-31 |
| Blackrock, Inc. | $1.82M | 9.01% | 23.07M | +994,831 | +4.51% | 2025-03-31 |
| State Street Corp | $826,802.00 | 4.09% | 10.46M | -9,614 | -0.09% | 2024-12-31 |
| Geode Capital Management, Llc | $487,545.00 | 2.41% | 6.17M | +157,948 | +2.63% | 2024-12-31 |
| Van Eck Associates Corp | $447,816.00 | 2.21% | 5.66M | +2M | +41.58% | 2024-12-31 |
| Nordea Investment Management Ab | $434,019.00 | 2.14% | 5.49M | +1M | +25.67% | 2024-12-31 |
| Norges Bank | $422,990.00 | 2.09% | 5.35M | +3M | +114.04% | 2024-12-31 |